Cerevast Therapeutics competitorsClear all

Intersect ENT's top competitors include Pressure BioSciences, SteadyMed Therapeutics and K2M Group.
Intersect ENT
Intersect ENT
Intersect ENT provides therapy solutions that enable ENT physicians to improve the quality of life of patients.
Pressure BioSciences
Pressure BioSciences
Pressure bioscience is focused on developing, marketing and selling proprietary laboratory instrumentation and associated consumables.
SteadyMed Therapeutics
SteadyMed Therapeutics
SteadyMed Therapeutics is a medical device company pursuing innovative devices for delivering injectable therapeutic drugs for pain relief, diabetes, and other chronic conditions.
K2M Group
K2M Group
K2M Group is a medical device company focused on treating some of the most difficult & challenging spinal pathologies.
Founding Date
Founding Date
2003
Founding Date
2004
Founding Date
2005
Founding Date
2004
Type
Type
Public
Type
Public
Type
Subsidiary
Type
Subsidiary
Tags
Locations
Locations
Menlo Park, US HQ
Locations
Easton, US HQ
Medford, US
Locations
San Ramon, US HQ
Rehovot, IL
Locations
Leesburg, US HQ
Rosenheim, DE
Uxbridge , GB
Employees
Employees
4022% increase
Employees
1721% increase
Employees
811% decrease
Employees
3123% decrease
Valuation ($)
Valuation ($)
510.2 m
Valuation ($)
6.3 m
Valuation ($)
N/A
Valuation ($)
N/A
Twitter followers
Twitter followers
942
Twitter followers
1.2 k
Twitter followers
87
Twitter followers
1.5 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
4
Number of tweets (last 30 days)
1
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
462379
Alexa Website Rank
338893
Alexa Website Rank
N/A
Alexa Website Rank
384816
Employee Rating
Employee Rating
2.7
Employee Rating
N/A
Employee Rating
4.4
Employee Rating
4.1

Financial

Revenue (est.)
Revenue (est.)
$109.1m (FY, 2019)
Revenue (est.)
$1.8m (FY, 2019)
Revenue (est.)
$1.1m (FY, 2017)
Revenue (est.)
$258m (FY, 2017)
Cost of goods
Cost of goods
$21.8m (FY, 2019)
Cost of goods
$1.2m (FY, 2019)
Cost of goods
N/A
Cost of goods
$88.6m (FY, 2017)
Gross profit
Gross profit
$87.4m (FY, 2019)
Gross profit
$612.9k (FY, 2019)
Gross profit
N/A
Gross profit
$169.4m (FY, 2017)
Net income
Net income
($43m) (FY, 2019)
Net income
($15.9m) (FY, 2019)
Net income
N/A
Net income
($37.1m) (FY, 2017)

Operating

Patents Issued
Patents Issued
77 (FY, 2016)
Patents Issued
N/A
Patents Issued
N/A
Patents Issued
415 (FY, 2016)

Funding

Total funding raised
Total funding raised
$ 102.9m
Total funding raised
$ 4.9m
Total funding raised
$ 35m
Total funding raised
$ 40m
For sources of this data, please see the company profile

View company profiles

Pressure BioSciences
HQ
Easton, US
Employees
17↑ 21% increase

Pressure bioscience is focused on developing, marketing and selling proprietary laboratory instrumentation and associated consumables.

View company
SteadyMed Therapeutics
HQ
San Ramon, US

SteadyMed Therapeutics is a medical device company pursuing innovative devices for delivering injectable therapeutic drugs for pain relief, diabetes, and other chronic conditions.

View company
K2M Group
HQ
Leesburg, US

K2M Group is a medical device company focused on treating some of the most difficult & challenging spinal pathologies.

View company